Detected ·
meduloc
$4M—
Meduloc closes a $4 million Series B financing round led by GenHenn Capital. The medtech company's FDA-cleared, flexible nitinol intramedullary implant is redefining fracture fixation, with funding to fuel its controlled alpha launch, clinical evidence generation, and commercial growth.
- Website
- www.meduloc.com
- linkedin.com/company/meduloc
- Amount
- $4 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-11 08:03:55 UTC
- Signal ID
- fe664565-2d5b-4998-b83b-f3e12e7ea207
As the API returns it
{
"id": "fe664565-2d5b-4998-b83b-f3e12e7ea207",
"created_at": "2026-08-11T08:03:55.727369Z",
"company_name": "meduloc",
"company_website_url": "www.meduloc.com",
"company_linkedin_url": "https://www.linkedin.com/company/meduloc",
"event_type": "funding",
"funding_amount": 4000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Meduloc closes a $4 million Series B financing round led by GenHenn Capital. The medtech company's FDA-cleared, flexible nitinol intramedullary implant is redefining fracture fixation, with funding to fuel its controlled alpha launch, clinical evidence generation, and commercial growth.*"
}